Equities

Veg of Lund AB (publ)

Veg of Lund AB (publ)

Actions
  • Price (SEK)1.14
  • Today's Change-0.045 / -3.80%
  • Shares traded8.81k
  • 1 Year change-25.13%
  • Beta2.0483
Data delayed at least 15 minutes, as of Apr 25 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Veg of Lund AB (publ) is a Sweden-based company that is primarily engaged in the food and beverages industry. The Company provides nutritious, filling and allergen-free plant-based drinks. Its offering consists of three flavors that contain a blend of potato, rapeseed oil and apple juice, as well as either blueberry, raspberry or sea buckthorn. The Company's products are free from added sugar as well as lactose, gluten and soy. Veg of Lund develops plant-based foods that meet patented methods for developing new food categories within the fast-growing market for plant-based foods. Veg of Lund's climate-smart products are sold in stores in Sweden, Great Britain and Ireland under the DUG brand.

  • Revenue in SEK (TTM)4.82m
  • Net income in SEK-19.91m
  • Incorporated2016
  • Employees7.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Klaria Pharma Holding AB (publ)7.15m-34.17m30.78m5.00--0.7483--4.31-0.3347-0.34980.07090.38620.0739--0.54261,429,400.00-35.34-37.27-58.14-51.56-----478.10-2,077.34---7.65-----100.00--71.17------
Fluicell AB3.34m-26.55m33.01m17.00--27.68--9.89-0.2286-0.22860.02960.00360.16240.68133.84196,352.90-129.20-87.55-222.48-126.0252.0772.97-795.51-650.230.5001------2.6822.18-22.90------
Modus Therapeutics Holding AB0.00-17.90m37.02m2.00--2.09-----1.04-1.040.000.4920.00----0.00-114.31-141.06-237.09-278.44-----------10.960.00------2.31------
Elicera Therapeutics AB11.23m-16.40m38.08m2.00--1.31--3.39-0.8289-0.82890.56770.82910.2936--8.135,615,030.00-42.88-40.06-66.66-49.74-----146.02-415.41----0.00--777.23--15.64------
Lipigon Pharmaceuticals AB16.41m-12.13m44.88m----1.58--2.74-0.3229-0.32290.25430.2250.7388--14.81---54.60-314.67-75.05-426.49-----73.91-488.14----------444.4467.83------
Veg of Lund AB (publ)4.82m-19.91m48.90m7.00--1.17--10.15-0.7328-0.73280.15191.010.133713.7414.40688,000.00-55.27-129.03-82.56-209.20-384.61-781.09-413.50-923.730.1256-12.900.1405--89.5739.8756.02---12.47--
Oncozenge AB0.00-15.90m50.31m----2.70-----1.36-1.360.001.590.00-------55.57---60.45----------------------65.91------
Pila Pharma AB1.46m-9.93m54.72m1.00--8.22--37.41-0.5304-0.53040.07670.280.1513--6.111,463,020.00-102.68-108.88-122.66-121.45-127.88-42.67-678.73-1,577.64---159.470.104---22.21--62.92------
Diagonal Bio AB23.00k-11.68m55.39m4.00--0.2530--2,408.11-0.1982-0.19820.00040.32210.0007--2.005,750.00-37.35---44.49---41,604.35---50,769.57--0.5105-104.20-----88.67--27.75------
Scandion Oncology A/S0.00-61.18m56.92m4.00--1.17-----1.52-1.520.001.190.00----0.00-63.25-45.09-76.67-52.65------------0.0158------48.89------
Coegin Pharma AB0.00-27.98m57.57m----4.42-----2.67-2.670.000.64040.00-------125.24-122.02-201.53-154.70-----------170.65--------20.60------
Orphazyme A/S0.00-40.65m59.23m1.00--2.66-----737.75-737.750.00403.340.00----0.00-68.42-76.08-94.18-105.34------------0.00------32.00------
Double Bond Phrmcutcl Intrntnl AB (publ)1.37m-17.34m60.41m10.00--10.76--44.09-0.1837-0.18370.01360.05560.1016--18.59137,033.00-128.49-80.90-198.98-106.45-241.22-686.41-1,265.24-1,360.03---217.550.00--10.25135.07-14.36------
PCI Biotech Holding ASA2.96m-20.11m62.66m7.00--1.62--21.17-0.5443-0.54430.08011.050.0556--0.6848---37.78-36.44-41.97-40.14-----679.43-1,055.43----0.0081---37.05-20.7863.13------
Prolight Diagnostics AB (publ)0.00-27.75m63.97m----0.1843-----0.0984-0.09840.000.6946-----------------------------------------13.84--
Chosa Oncology AB73.00k-23.94m67.79m----3.89--928.67-0.3524-0.35240.00130.26840.003--0.013---96.68-51.96-178.66-61.92-----32,798.63-708.47---97.97-----98.21--28.33------
Data as of Apr 25 2024. Currency figures normalised to Veg of Lund AB (publ)'s reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.